Vaccination of Toronto s homeless well underway with about 1,000 getting a shot cp24.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cp24.com Daily Mail and Mail on Sunday newspapers.
Author of the article:
GlobeNewswire
Publishing date: Mar 01, 2021  â¢Â March 1, 2021  â¢Â 3 minute read  â¢Â
Article content
MONTREAL, March 01, 2021 (GLOBE NEWSWIRE) â Knight Therapeutics Inc. (TSX: GUD), (âKnightâ) a pan-American (ex-USA) specialty pharmaceutical company, announced today the Canadian commercial availability of IBSRELA (tenapanor), a first-in-class therapy for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults. Knight has the exclusive right to commercialize IBSRELA in Canada under the terms of a license agreement entered into with Ardelyx, Inc. (NASDAQ: ARDX) in March 2018, which license agreement also provides Knight with exclusive rights to commercialize tenapanor for hyperphosphatemia in Canada.  IBSRELA was approved by Health Canada on April 15, 2020 and is now covered by most private insurance companies in Canada.
With most long-term care residents vaccinated, restoring their quality of life is urgent, experts say
Many family members are asking why their loved ones in long-term care continue to live under tight COVID-19 restrictions even after they ve been vaccinated. Doctors say giving seniors back some normalcy in their lives while keeping them safe is an urgent priority.
Social Sharing